AJELLO, Antonino
 Distribuzione geografica
Continente #
NA - Nord America 596
EU - Europa 448
AS - Asia 103
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.149
Nazione #
US - Stati Uniti d'America 590
IE - Irlanda 141
SE - Svezia 121
CN - Cina 93
UA - Ucraina 65
DE - Germania 40
GB - Regno Unito 34
FI - Finlandia 22
BE - Belgio 15
IN - India 8
CA - Canada 6
IT - Italia 6
RU - Federazione Russa 3
CL - Cile 1
ES - Italia 1
EU - Europa 1
IR - Iran 1
TR - Turchia 1
Totale 1.149
Città #
Dublin 141
Jacksonville 137
Chandler 113
Nyköping 74
Beijing 59
Ann Arbor 54
Ashburn 39
Lancaster 22
Cambridge 21
Medford 21
Princeton 21
Woodbridge 20
Des Moines 16
Boardman 15
Brussels 15
Pune 8
Dearborn 7
Jinan 6
Auburn Hills 5
Ottawa 5
Haikou 4
Mountain View 4
San Mateo 4
Changsha 3
Guangzhou 3
Hangzhou 3
Los Angeles 3
Salerno 3
Bari 2
Nanjing 2
Saint Petersburg 2
Taiyuan 2
Taizhou 2
Washington 2
Wilmington 2
Ardabil 1
Boston 1
Chicago 1
Chongqing 1
Fort Payne 1
Fuzhou 1
Granby 1
Hefei 1
Helsinki 1
Lanzhou 1
Milan 1
Nanchang 1
Norwalk 1
Phoenix 1
Saint Louis 1
Seattle 1
Tianjin 1
Zhengzhou 1
Totale 858
Nome #
Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma 85
Class I HLA antigens hepatic display and beta-2-microglobulin serum values in chronic hepatitis C: Effect of treatment with recombinant alpha interferon 79
Serum thrombopoietin in chronic liver disease: Relation to severity of the disease and spleen size 75
Infezione da virus dell'epatite C e tossicodipendenza 70
Randomised trial of two different daily doses of interferon- alpha versus classical therapy in treatment-naive patients with chronic hepatitis C 68
Efficacy of interferon treatment (IFN) in elderly patients with chronic hepatitis C 62
Interferon retreatment of patients with chronic hepatitis C. A long-term follow-up 55
FOCAL LYMPHOCYTIC AGGREGATES IN CHRONIC HEPATITIS-C - OCCURRENCE, IMMUNOHISTOCHEMICAL CHARACTERIZATION, AND RELATION TO MARKERS OF AUTOIMMUNITY 54
[Behavior of anti-HBc IgM in acute and chronic hepatitis]. 53
Ten year follow-up of patients with chronic hepatitis C treated with interferon 52
HCV INFECTION, HEPATIC HLA DISPLAY AND COMPOSITION OF THE MONONUCLEAR CELL INFLAMMATORY INFILTRATE IN CHRONIC-ALCOHOLIC LIVER-DISEASE 51
The rational use of albumin in patients with cirrhosis and ascites. A Delphi study for the attainment of a consensus on prescribing standards 50
Serum chromogranin-A in hepatocellular carcinoma: diagnostic utility and limits. 50
Tamoxifen in the treatment of Hepatocellular Carcinoma: 5-year results of the CLIP-1 multicentre randomized controlled trial 49
La steatoepatite non alcolica, fattori di rischio e aspetti umorali 47
PREVALENCE OF ANTI-HCV ANTIBODIES IN PATIENTS WITH CHRONIC LIVER-DISEASE AND ITS RELATIONSHIP TO HBV AND HDV INFECTIONS 47
Prognostic factors of survival in complicated viral and alcoholic cirrhosis without hepatocellular carcinoma. A retrospective study. 45
NON-ALCOHOLIC FATTY LIVER DISEASE: A MULTICENTRE CLINICAL STUDY BY THE ITALIAN ASSOCIATION FOR THE STUDY OF THE LIVER 44
High circulating D-dimers are associated with ascites and hepatocellularcarcinoma in liver cirrhosis. 44
Soluble CD30 serum levels before and after treatment with alpha-interferon in patients with chronic hepatitis 40
Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma. 37
Totale 1.157
Categoria #
all - tutte 3.664
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.664


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20196 0 0 0 0 0 0 0 0 0 1 4 1
2019/2020233 43 23 1 19 2 12 25 22 2 50 33 1
2020/2021149 21 3 37 7 3 22 1 20 3 14 10 8
2021/2022137 1 27 4 5 6 2 4 5 3 18 19 43
2022/2023427 27 42 32 23 44 42 1 35 165 2 11 3
2023/202483 6 14 5 10 10 28 0 10 0 0 0 0
Totale 1.157